首页> 外文期刊>Phytotherapy research: PTR >Topical Herbal Formulae in the Management of Psoriasis: Systematic Review with Meta-Analysis of Clinical Studies and Investigation of the Pharmacological Actions of the Main Herbs
【24h】

Topical Herbal Formulae in the Management of Psoriasis: Systematic Review with Meta-Analysis of Clinical Studies and Investigation of the Pharmacological Actions of the Main Herbs

机译:银屑病治疗中的局部草药配方:对临床研究和主要草药的药理作用进行荟萃分析的系统评价

获取原文
获取原文并翻译 | 示例
           

摘要

This systematic review and meta-analysis of randomized controlled trials (RCTs) examined the topical use of multi-herbal formulations for the management of psoriasis vulgaris. Studies were identified from PubMed, Cochrane library, EMBASE, and the Chinese databases CNKI and CQVIP. Methods were according to the Cochrane Handbook and meta-analyses used RevMan 5.1. Nine studies met the inclusion/exclusion criteria. The comparisons were with placebo and/or anti-psoriatic pharmacotherapy (APP) with two studies having three arms. The pooled meta-analysis data indicated the topical herbal formulae improved overall clinical efficacy (defined as 50% improvement or greater) when compared with: topical placebo (plus oral herbal co-intervention); topical APP alone; and topical APP (plus pharmaceutical co-intervention). Improvement was evident in Modified Psoriasis Area and Severity Index (PASI) score when topical herbal formula was compared to placebo (plus oral herbal co-intervention). No serious adverse events were reported. The most commonly used herbs were Sophora flavescens root and Lithospermum erythrorhizon root. Experimental studies reported that these herbs and/or their constituents have anti-inflammatory, anti-proliferative, anti-angiogenic, and tissue repair actions. These actions may at least partially explain the apparent benefits of the topical multi-herbal formulations in psoriasis.
机译:这项对随机对照试验(RCT)的系统评价和荟萃分析检查了多草药制剂在寻常型银屑病治疗中的局部使用。研究人员从PubMed,Cochrane库,EMBASE以及中文数据库CNKI和CQVIP中进行了鉴定。方法根据《 Cochrane手册》进行,荟萃分析使用RevMan 5.1。九项研究符合纳入/排除标准。比较采用安慰剂和/或抗银屑病药物疗法(APP),两项研究三个方面。汇总的荟萃分析数据表明,与以下情况相比,局部草药配方改善了整体临床疗效(定义为改善50%或更高):局部安慰剂(加口服草药联合干预);单独使用局部应用程序;和局部APP(加上药物联合干预)。当将局部草药配方与安慰剂(加上口服草药联合干预)进行比较时,改良的牛皮癣面积和严重性指数(PASI)评分明显改善。没有严重不良反应的报道。最常用的草药是苦参(Sophora flavescens)根和紫草(Lithospermum erythrorhizon)根。实验研究表明,这些草药和/或其成分具有抗炎,抗增殖,抗血管生成和组织修复的作用。这些作用可能至少部分解释了局部多草药制剂在牛皮癣中的明显益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号